HIV Among Women: A Growing Concern in Childbearing Years

When we talk about HIV/AIDS, one crucial aspect often demands urgent attention: the disease’s impact on women during their childbearing years. This isn’t just a women’s health issue-it’s a matter that shapes entire families, communities, and the future of public health systems worldwide. Understanding the extent of HIV infection among women of reproductive age helps us grasp the full scope of this ongoing global health challenge.

The global picture: Women bearing the burden
Sub-Saharan Africa: At the epicenter of the crisis
When mothers are infected: The devastating impact on children
The harsh reality of child mortality
India’s challenge: A different landscape with unique obstacles
Broader societal ripples: How maternal HIV reshapes communities
Public health system pressures
Family and economic consequences
Moving forward: What the numbers tell us

The global picture: Women bearing the burden

Across the world, women and girls comprise approximately 53% of all people living with HIV, making them a demographic group that faces disproportionate risk. The numbers tell a sobering story. In recent years, the disease burden among women of childbearing age has shown both progress and persistent challenges.

Globally, there were 670,804 new AIDS cases in women of childbearing age in 2021 alone. While age-standardized incidence rates have shown a declining trend, the absolute numbers remain concerningly high. What makes this particularly troubling is that women and girls accounted for 45% of all new HIV infections in 2024, highlighting the continued vulnerability of this population.

Sub-Saharan Africa: At the epicenter of the crisis

The regional disparities in HIV prevalence among women are stark and demand focused attention. Sub-Saharan Africa comprises roughly 81.1 percent of the worldwide infected female population, making it the region most heavily affected by this epidemic. In certain areas, the situation is even more acute.

In sub-Saharan Africa, women of childbearing age comprise 61% of people living with HIV, accounting for over 12 million women. The concentration of cases in this region reflects complex factors including healthcare access, socioeconomic conditions, and gender-based vulnerabilities that increase women’s risk of infection.

Perhaps most concerning is the pattern of infection among young women. Every week, 4000 adolescent girls and young women aged 15-24 years became infected with HIV in 2024-3300 of these infections occurred in sub-Saharan Africa. This means that young women in their prime reproductive years face extraordinary risk, with implications that extend far beyond individual health.

When mothers are infected: The devastating impact on children

The consequences of HIV infection in women of childbearing age ripple outward, affecting not just the women themselves but their children and families. Mother-to-child transmission remains a critical pathway through which HIV spreads to the next generation, and the mortality statistics for infected infants paint a grim picture.

The harsh reality of child mortality

Without intervention, 25 to 45 percent of infants born to HIV-positive mothers become infected. The progression of disease in these young children is often rapid and devastating. Without access to testing and treatment, 50% of children with HIV will die by the age of 2, and 80% will not live to their fifth birthday.

Research from Rwanda illustrates the severity of outcomes for HIV-infected children. In a prospective study conducted in Kigali, the cumulative probability of death in 54 HIV-infected children was 0.26 at 1 year, 0.45 at 2 years, and 0.62 at 5 years. To put this in perspective, HIV-uninfected children had 15 times lower mortality at 5 years of age.

The broader impact on child survival is equally troubling. Mother-to-child transmission of HIV ranges from 15 to 45%, with up to 15-20% resulting from breastfeeding. A community-based study in Uganda found that HIV-infected children had 2-year mortality rates of 547 per thousand, compared to 166 per thousand for HIV-negative children of HIV-positive mothers, and 128 per thousand for children of HIV-negative women.

India’s challenge: A different landscape with unique obstacles

While India’s HIV prevalence is lower than that of many African nations, the sheer size of its population means that the absolute numbers remain significant. The country faces distinct challenges in addressing HIV among women of childbearing age.

According to government data, nationally, there were an estimated 20.52 thousand pregnant women who would require ART to prevent mother-to-child transmission of HIV in 2019. More recent figures show that in 2023, India reported about 13 thousand live births among HIV infected pregnant women.

The geographic distribution of cases reveals important patterns. States like Maharashtra, Bihar, and Uttar Pradesh account for the highest PMTCT needs, but many smaller states and rural areas face significant challenges in service delivery. Regional disparities in healthcare infrastructure, awareness, and access to treatment create uneven outcomes across the country.

India’s unique demographic and cultural context adds layers of complexity. Research reveals that 40.7% of HIV-infected women in India were diagnosed during childbearing years, often during their first pregnancy. Additionally, 27.2% learned of their HIV status only after their husband’s death, highlighting how gender dynamics and family structures influence diagnosis patterns.

Broader societal ripples: How maternal HIV reshapes communities

The impact of HIV among women of childbearing age extends far beyond health statistics. It fundamentally alters public health priorities and family dynamics in affected communities.

Public health system pressures

HIV in women of reproductive age forces health systems to balance multiple urgent needs. Prevention of mother-to-child transmission programs require sustained investment in testing, counseling, and antiretroviral therapy. 84% of pregnant women living with HIV had access to antiretroviral medicines to prevent transmission of HIV to their child in 2024, representing significant progress but also highlighting that gaps remain.

Healthcare systems must also address the broader needs of affected families. When mothers are infected, children face increased vulnerability even if they remain HIV-negative. Orphanhood, economic hardship, and interrupted education create cascading effects that strain social support systems and perpetuate cycles of poverty and disease.

Family and economic consequences

The economic burden on families dealing with maternal HIV is substantial. Treatment costs, reduced work capacity, and the need for child care all place financial strain on households. In many contexts, women already face economic disadvantages, and HIV infection compounds these challenges.

The social stigma surrounding HIV adds another dimension of difficulty. Women may face discrimination, abandonment by partners, or exclusion from their communities. These social factors can delay diagnosis, reduce treatment adherence, and worsen health outcomes for both mothers and children.

Moving forward: What the numbers tell us

The extent of HIV infection among women of childbearing age reveals both the scale of the challenge and the areas where intervention can have the greatest impact. While global efforts have reduced new infections and improved treatment access, significant work remains.

Prevention of mother-to-child transmission represents one of the most effective ways to break the cycle of HIV. Ensuring that all pregnant women have access to testing and treatment can dramatically reduce new pediatric infections. Countries that have invested heavily in PMTCT programs have seen remarkable results, demonstrating that progress is possible with adequate resources and political will.

Addressing HIV among women also requires tackling the underlying social and economic factors that increase vulnerability. Gender inequality, limited access to education, economic dependence, and gender-based violence all contribute to women’s heightened risk. Comprehensive responses must address these root causes alongside medical interventions.

What do you think? How can communities better support women of childbearing age in accessing HIV prevention and treatment services? What role should cultural sensitivity play in designing programs to address HIV among women in diverse settings?

References

PDF 📄

Table of Contents

The global picture: Women bearing the burden 🔗

Sub-Saharan Africa: At the epicenter of the crisis 🔗

When mothers are infected: The devastating impact on children 🔗

The harsh reality of child mortality 🔗

India’s challenge: A different landscape with unique obstacles 🔗

Broader societal ripples: How maternal HIV reshapes communities 🔗

Public health system pressures 🔗

Family and economic consequences 🔗

Moving forward: What the numbers tell us 🔗